Vivek Kopparthi

Vivek Kopparthi Co-founder & CEO of NeoLight

Vivek Kopparthi is the co-founder & CEO of NeoLight, a medical device company advancing state-of-the-art technologies for neonatal health conditions. The company currently markets technologies for retinopathy of prematurity, Jaundice, retinoblastoma, non-nutritive sucking, infant weight loss, abusive head trauma, neonatal seizure detection and brain monitoring. NeoLight is currently active in 60+ countries and most importantly, and just crossed their 200,000th baby treated!

Vivek is also a co-founder of PriZm Therapeutics, a rare disease company focused on solving for an ultra-rare neonatal disease called MCT8 deficiency. There are 7000 rare diseases identified, and mankind has a cure only for 200 of them. Babies suffering from this health condition are bed-ridden, prone to seizures, can’t walk nor talk and die before hitting teenage. PriZm is advancing a Phase III drug for pregnant mothers to help solve the condition at the 8th week of pregnancy.

Vivek is based out of Phoenix and also chairs the Next-Gen Council at Arizona State University, his alma matter. He has won numerous awards including TimesNow NRI of the year and Forbes 30 under 30. Recently, he was on the cover of the Entrepreneur magazine.